KRISTINA DOWNING: Open Payments
NPI 1518218718 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 36 payments from 16 companies in 2025. Trend: 2023 $924 · 2024 $1,314 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $163 |
| PFIZER INC. | 4 | $69 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $62 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $61 |
| Abbott Laboratories | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Amgen Inc. | 2 | $29 |
| Novo Nordisk Inc | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: VRAYLAR, XIFAXAN, QULIPTA, PREVNAR 20, SHINGRIX, Ozempic, UBRELVY, BREZTRI.
Industry payments across NE — which companies pay providers there.
